Feature | September 14, 2009

3D TEE Images Identify Atrial Degeneration, Recurrence in AF

September 9, 2009 - Integrated backscatter (IBS) images were acquired with transesophageal echocardiography (TEE) and 3-dimensional image reconstruction to identify an increase in atrial degeneration that might predict the occurrence of atrial fibrillation (AF) before left atrium (LA) dilation.

In the study Atrial Fibrillation: Usefulness of Integrated Backscatter Transesophageal Echocardiography, recognized that one of the causes of AF is pathological degeneration of the LA.

Using IBS images acquired with TEE and 3-dimensional image reconstruction, they found that the IBS values of the LA, which reflect degeneration of LA tissue, were significantly higher in patients with paroxysmal AF than in those without AF; LA dimensions were similar.

They concluded that IBS-TEE can identify an increase in atrial degeneration that might predict the occurrence of AF before LA dilation.

Reference: Kubota, Tomoki. Atrial Fibrillation: Usefulness of Integrated Backscatter Transesophageal Echocardiography. Journal of the American College of Cardiology, Volume 54, No. 13. September 22, 2009.

Tomoki Kubota, Masanori Kawasaki, Nobuhiro Takasugi, Urara Takeyama, Yoshiyuki Ishihara, Munenori Okubo, Takahiko Yamaki, Shinsuke Ojio, Takuma Aoyama, Masazumi Arai, Kazuhiko Nishigaki, Genzou Takemura, Hisayoshi Fujiwara, Shinya Minatoguchi

Related Content

pediatric echocardiograms, cardiovascular ultrasound, therapy dog impact, animal-assisted therapy, Human Animal Bond Research Initiative, HABRI
News | Cardiovascular Ultrasound| October 25, 2016
The Human Animal Bond Research Initiative (HABRI) announced it has awarded a $44,000 grant to Duke University School of...
Analogic Corp., bk3500 ultrasound system, cardiac imaging software, ACEP 2016, RSNA 2016
News | Cardiovascular Ultrasound| October 18, 2016
Analogic Corp. announced last week that it will introduce its new premium cardiac imaging software for the bk3500...
Philips, Lumify smart-device ultrasound, S4-1 cardiac transducer, RSNA 2016
Technology | Cardiovascular Ultrasound| October 14, 2016
Philips announced at The American College of Emergency Physicians' (ACEP) annual meeting that it has received 510(k)...
GE Healthcare, Optison ultrasound contrast agent, FDA labeling change, cardiac shunts, intra-arterial injection
Technology | Contrast Media| October 04, 2016
GE Healthcare announced that the U.S. Food and Drug Administration (FDA) has approved a label change for the ultrasound...
Sci-image, Scimage, CVIS, CIIMS, Cpacs c-pacs, cardiovascular information system

Today's cardiovascular information systems need to incorporate all facets of the cardiology department, including subspecialties, to allow a complete picture of a patient's record. These data also need to be able to be shared with enterprise data systems, such as the electronic medical record (EMR). This image is from ScImage, illustrating the various aspects that integrate to make up a complete CVIS. 


Feature | September 29, 2016 | Val Kapitula, RT(R), PMP, CIIP
Cardiovascular information and imaging systems (CVIS) have existed for many years in the dedicated sub-specialty area
GE Healthcare, Vivid iq portable cardiovascular ultrasound, RSNA 2016, launch
Technology | Cardiovascular Ultrasound| September 22, 2016
September 22, 2016 — GE Healthcare announced the global commercial launch of its new generation of high-end portable
Transesophageal Echo, TEE. Interventional echocardiography, interventional echo, Philips, CX50

Transesophageal echo (TEE) has become an essential part of the new transcatheter structrual heart therapies, giving rise to a new sub-speciality of interventional echocardiography.  

Feature | Cath Lab Navigation Aids| September 21, 2016 | Dave Fornell
The rapid growth of transcatheter structural heart procedures and the need for increased use of echocardiography as a
Toshiba, Aplio 500 Platinum ultrasound, International Contrast Ultrasound Society, ICUS, live case, contrast-enhanced ultrasound
News | Ultrasound Imaging| September 07, 2016
September 7, 2016 — Toshiba America Medical Systems Inc.
Absorb, bioresorbable stent, FDA approval, FDA approves, FDA clears, most popular content, most popular stories, DAIC

The FDA clearance of the first bioresorbable stent, the Abbott Absorb, the first week of July has been the most popular story so far for all of 2016. It is the first fully dissolving stent approved for the U.S. market and many experts say this technology could be a paradigm shift in coronary and peripheral therapies in the coming years as the technology improves. 

Feature | August 05, 2016 | Dave Fornell
mitral valve surgery outcomes, twisting of the heart, echocardiography, NICSMR, JACC Basic to Translational Science
News | Heart Valve Technology| July 20, 2016
A novel study has found a simple pre-operative echocardiographic measurement of the amount of torsion of the heart...
Overlay Init